Sponsor or institution
Clinical trials and research at Guerbet
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Guerbet that are recruiting, at sites in 12 countries (most in Canada (2), France (2), Germany (2)). By phase: Phase 3 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 12Countries
All recruiting trials (2)
-
Gadolinium MRI compare two contrast agents for artery disease in adults
This study tests whether gadopiclenol can provide diagnostic images as good as gadoterate meglumine for adults with suspected steno-occlusive artery disease using MRI.
-
Effects of Gadolinium-based Contrast Media on Movement and Mental Skills
This study is testing how repeated use of gadolinium-based contrast agents during imaging tests affects movement and thinking skills in healthy adults.
Quick answers
How many clinical trials run by Guerbet are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 12 countries. The most sites are in Canada (2 trials), France (2 trials), Germany (2 trials), Italy (2 trials), South Korea (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.